Drug Shortage Report for RAN-NABILONE
Report ID | 12342 |
Drug Identification Number | 02358085 |
Brand name | RAN-NABILONE |
Common or Proper name | RAN-NABILONE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-05-03 |
Actual start date | 2017-05-03 |
Estimated end date | Unknown |
Actual end date | 2017-12-31 |
Shortage status | Resolved |
Updated date | 2019-02-01 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-02-01 | French | Compare |
v4 | 2019-02-01 | English | Compare |
v3 | 2017-06-08 | French | Compare |
v2 | 2017-06-08 | French | Compare |
v1 | 2017-06-08 | English | Compare |
Showing 1 to 5 of 5